Quick Summary
Bladderwrack (Fucus vesiculosus) is a brown seaweed rich in bioactive compounds such as phlorotannins, fucoidan, and alginate. It has been traditionally used in various cultures and is currently being researched for potential metabolic, cardiovascular, anti-inflammatory, anticancer, and skin health benefits. The existing evidence mainly comes from in vitro, animal, and some human clinical trials and remains preliminary, with further clinical validation needed.
What is Bladderwrack?
Bladderwrack is a type of brown marine algae found along the coasts of the North Sea, the western Baltic Sea, and the Atlantic and Pacific Oceans. It contains a variety of bioactive substances, including polysaccharides and polyphenols, which have attracted scientific interest for their possible health-supporting properties.
Traditional Uses
Traditionally, bladderwrack has been used in folk medicine, often to support thyroid health, due to its natural iodine content. It has also been applied topically or consumed for skin conditions, inflammation, and as a general health tonic in some cultures.
Active Compounds
- Phlorotannins: Polyphenolic compounds with antioxidant potential
- Fucoidan: Sulfated polysaccharides believed to have multiple bioactivities
- Alginate: Polysaccharides contributing to gel-forming and potential metabolic effects
- Iodine: Essential mineral influencing thyroid function
Potential Benefits with Evidence Levels
- Metabolic Syndrome and Cardiometabolic Risk — Moderate human clinical evidence: Some clinical trials and reviews suggest extracts of bladderwrack may help manage features of metabolic syndrome, including dyslipidemia, blood glucose regulation, and blood pressure control, likely due to its polysaccharides and polyphenols. More robust trials are needed to confirm these effects.
- Glycemic Control — Limited human clinical evidence: Preliminary studies indicate bladderwrack may lower fasting and postprandial plasma glucose levels, potentially aiding diabetes or prediabetes management, though evidence remains limited.
- Cardiovascular Health (Dyslipidemia and Blood Pressure) — Moderate human clinical evidence: Meta-analyses indicate brown seaweed supplements, including bladderwrack, may reduce total and LDL cholesterol and lower blood pressure, supporting cardiovascular health.
- Anti-inflammatory and Antioxidant Effects — Preclinical evidence (in vitro and in vivo): Laboratory studies show bladderwrack compounds can modulate inflammatory pathways (e.g., NF-κB, MAPK) and reduce oxidative stress markers.
- Cancer Therapy (Supportive and Experimental) — Animal and in vitro evidence: Fucoidan exhibits antitumor activity in experimental models through apoptosis and immune modulation; however, clinical efficacy in humans is unproven.
- Musculoskeletal and Skin Health — Preclinical evidence: Early research suggests potential benefits for skin and muscle health due to antioxidant, anti-inflammatory, and moisturizing properties.
Side Effects
Clinical trials have not consistently reported significant adverse effects with bladderwrack use. However, excessive consumption poses a risk related to its iodine content, which may impact thyroid function in susceptible individuals.
Drug Interactions
While direct evidence of drug interactions is limited, caution is advised in individuals using thyroid medications or anticoagulants, given bladderwrack’s iodine content and bioactive compounds that might influence metabolism or immune response. Consultation with healthcare providers is recommended before use.
Who Should Avoid It
Individuals with thyroid disorders or those taking thyroid hormone medications should exercise caution due to the iodine content. Pregnant and breastfeeding women should avoid use or only take it under healthcare supervision, given limited safety data. More conclusive evidence is needed to define clear contraindications.
Evidence Limitations
The majority of evidence comes from laboratory and animal studies, with human clinical data being limited, small-scale, or variable in extract formulation and dosage. These factors reduce the generalizability and reproducibility of results. Long-term safety and efficacy remain unclear. Well-designed, larger randomized controlled trials are warranted.
References
- Clinical Efficacy of Brown Seaweeds Ascophyllum nodosum and Fucus vesiculosus in the Prevention or Delay Progression of the Metabolic Syndrome: A Review of Clinical Trials. (2021)
- Effect of brown seaweed on plasma glucose in healthy, at-risk, and type 2 diabetic individuals: systematic review and meta-analysis. (2022)
- How Do Brown Seaweeds Work on Biomarkers of Dyslipidemia? A Systematic Review with Meta-Analysis and Meta-Regression. (2023)
- Edible Algae Reduce Blood Pressure in Humans: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. (2025)
- Fucoidan in cancer therapy: from biomedical application to medicinal chemistry approach. (2025)
- Phlorotannins from Phaeophyceae: Structural Diversity, Multi-Target Bioactivity, Pharmacokinetic Barriers, and Nanodelivery System Innovation. (2025)
- Beneficial Effects of Seaweed-Derived Components on Metabolic Syndrome via Gut Microbiota Modulation. (2023)
- Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications. (2025)
- Brown Seaweed Food Supplementation: Effects on Allergy and Inflammation and Its Consequences. (2021)
- Phlorotannins and glycolipid metabolism: comprehensive regulatory roles mediated by the gut microbiota. (2026)
- Clinical Studies of the Safety and Efficacy of Macroalgae Extracts in Cosmeceuticals. (2021)
Last Reviewed
June 2024
Disclaimer: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbal products, especially if you are pregnant, nursing, have existing health conditions, or are taking medications.